Molson Coors Hit with Class Action Lawsuit

Complaint accuses CEO and CFO of making false and misleading statements.

New York law firm Bernstein Liebhard has filed a class action lawsuit against Molson Coors Brewing, accusing the company of making false and misleading statements that resulted in misreporting net income.

The firm, which is seeking a lead plaintiff, said the suit is on behalf of those who purchased or acquired the securities between Feb. 14, 2017, and Feb. 12, 2019.  The suit also names as defendants Molson Coors Chief Executive Officer and President Mark Hunter and Chief Financial Officer Tracey Joubert.

According to the lawsuit, Molson Coors failed to disclose that it did not properly reconcile the outside basis deferred income tax liability for the company’s investment in its MillerCoors, LLC partnership. As a result, it misreported net income in its consolidated financial statements for the fiscal years ending Dec. 31, 2016, and Dec. 31, 2017, resulting in an overall downward revision to net income.

The suit also accuses Molson Coors of lacking adequate internal controls over financial reporting, which it said led to statements about its business, operations, and prospects that “were materially false and misleading and/or lacked a reasonable basis at all relevant times.”

For more stories like this, sign up for the CIO Alert newsletter.

In a Feb. 12 SEC filing, Molson Coors said that the audit committee of the its board of directors, after consulting with its accountants PricewaterhouseCoopers, “concluded that the company’s previously issued consolidated financial statements as of and for the years ended December 31, 2017, and December 31, 2016, should be restated and no longer be relied upon.”

The company also said that it “concluded that the previously issued 2017 and 2016 consolidated financial statements were misstated.”

As a result, the company restated its financial statements for the year ended Dec. 31, 2016, to increase its deferred tax liabilities and deferred tax expense by $399.1 million, with a corresponding decrease in net income and earnings per share. It also restated its financial results for fiscal year 2017 that resulted in an aggregate $247.7 million increase to the company’s deferred tax liabilities and corresponding decrease in retained earnings and total equity.

In the filing, Molson Coors also said that it “has determined that a material weakness existed in the company’s internal control over financial reporting,” adding that it “did not design appropriate controls to identify and reconcile deferred income taxes associated with the accounting for acquired partnership interests.”

The suit says that as a result of this disclosure, shares of Molson Coors fell $6.17 per share or approximately 9.5% to close at $59.19 per share on February 12, 2019, damaging investors.

“Unbeknownst to investors, the defendants repeatedly and materially misstated Molson’s financial condition in filings with the SEC,” says the suit, “while falsely representing that Molson’s financial statements complied with GAAP and that its internal controls were effective. As a result, class members were materially misled.”

The suit alleges that because of their positions with the company and access to material non-public information available to them, Hunter and Joubert knew that the adverse facts “had not been disclosed to and were being concealed from the public and that the positive representations being made were false and misleading.”

Additionally, the suit says the company and the two executives “knew that the public documents and statements issued or disseminated in the name of the company were materially false and misleading; knew that such statements or documents would be issued or disseminated to the investing public; and knowingly and substantially participated or acquiesced in the issuance or dissemination of such statements or documents as primary violations of the federal securities laws.”

Related Stories:

Pension Fund Wins Securities Fraud Trial Against Puma Biotech

American Century Wins 401(k) Class Action Lawsuit

MillerCoors Purchases Group Annuity Contract

Tags: , , ,

ETFs Are in Higher Demand from Insurers

Buyers of the funds triple in number, although these securities are still a small part of carriers’ portfolios, study says.

Insurance companies, which historically favor bonds, have inched up their use of exchange-traded funds, which trade like stocks. The number of insurers investing in ETFs has more than tripled through 2017, to 612, according to consulting firm Greenwich Associates. That’s 62% of all insurance carriers.

At yearend 2017, US insurance companies had $27.2 billion invested in ETFs, a 37% increase from 2016, according to the study, done for State Street Global Advisors, a major ETF issuer (it launched the first one in 1993). To be sure, this is less than 1% of all insurance assets.

Some two-thirds of insurance assets are in bonds, which insurers prefer because of fixed income’s lower volatility and steady income stream from interest. Bonds’ maturities are customarily matched to clients’ ages and other actuarial criteria, with the aim of best being able to pay out when policyholders or their beneficiaries file claims.

Aiding the rise in insurer ETF usage is the National Association of Insurance Commissioners decision in April 2017 to change the accounting valuation method of bond ETFs that the carriers hold. Before, fixed-income ETFs were valued by their price, which can fluctuate substantially on the stock exchanges where they trade. Now, the industry’s chief regulatory body ruled, these ETFs can be valued by the underlying bonds in their portfolios.

Never miss a story — sign up for CIO newsletters to stay up-to-date on the latest institutional investment industry news.

The study found that, of the almost 40% of insurers that don’t invest in ETFs, most avoid them because of state laws or internal company guidelines prohibiting such investments. Their stock-like nature likely is the underlying reason.

The second-biggest reason for shunning ETFs also has to do with returns: These insurers don’t think ETFs will help them beat market benchmarks. That’s no surprise, since ETFs generally track market indexes.

Among non-users, though, some 82% said they would reconsider in the future.

Of the insurance outfits that do use ETFs, the attraction ranges from their low cost (as primarily index-based products, they don’t need a lot of expensive analysts and traders to function) and elimination of “cash friction.”

This is where an investor sells an asset and parks the cash waiting to buy something else with it. Cash doesn’t pay a lot of interest. Presumably, owning an index-linked vehicle, like an ETF, which contains many securities, lowers the need to be trading individual stocks, bonds, and other assets.

The study found that ETF investment was almost evenly split between life (42%) and property-casualty companies (38%), with health and reinsurance insurers making up the rest. There was also a fairly even ownership split among small (less than $5 billion in assets), medium ($5 billion to $50 billion), and large (above $50 billion) insurance companies.

Related Stories:

State Street Hits $2Trillion in Global ETFs Under Management

Why Index Fund Creator Jack Bogle Hated ETFs

Smart Beta ETFs Get Even More Popular

Tags: , , , , ,

«